Efficacy of Nicotine in Preventing COVID-19 Infection (NICOVID-PREV)
Daily active smokers are infrequent among outpatients or hospitalized patients with COVID-19. Several arguments suggest that nicotine is responsible for this protective effect via the nicotinic acetylcholine receptor (nAChR).
Nicotine may inhibit the penetration and spread of the virus and have a prophylactic effect in COVID-19 infection.
You don't have to smoke it, just can use a lozenge.
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches - https://files.catbox.moe/s6glgy.pdf
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host - https://files.catbox.moe/h3lsx3.pdf
CBD helps reduce lung damage from COVID by increasing levels of protective peptide – https://files.catbox.moe/76fc3s.pdf
In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues - https://files.catbox.moe/5glqzb.pdf
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 - https://files.catbox.moe/oq3tew.pdf
The potential of cannabidiol in the COVID‐19 pandemic - https://files.catbox.moe/hlnl5x.pdf